Rishira Fernando Professor Alan Thomas Dr Calum Hamilton Dr Rory Durcan Sally Barker et al. | Identifying parkinsonism in mild cognitive impairment. | 2024 |
|
Dr Paul Donaghy Dr Calum Hamilton Dr Rory Durcan Dr Sarah Lawley Sally Barker et al. | Clinical symptoms in mild cognitive impairment with Lewy bodies: Frequency, time of onset, and discriminant ability | 2023 |
|
Dr Gemma Roberts Dr Joseph Kane Dr James Lloyd Dr Michael Firbank Dr Paul Donaghy et al. | Can early phase cardiac [123I]mIBG images be used to diagnose Lewy body disease? | 2022 |
|
Dr Paul Donaghy Dr Joanna Ciafone Dr Rory Durcan Dr Calum Hamilton Sally Barker et al. | Mild cognitive impairment with Lewy bodies: neuropsychiatric supportive symptoms and cognitive profile | 2022 |
|
Dr Matt Ingram Dr Sean Colloby Dr Michael Firbank Dr James Lloyd Professor John O'Brien et al. | Spatial covariance analysis of FDG-PET and HMPAO-SPECT for the differential diagnosis of dementia with Lewy bodies and Alzheimer's disease | 2022 |
|
Dr Gemma Roberts Dr Paul Donaghy Dr James Lloyd Dr Rory Durcan Dr George Petrides et al. | Accuracy of dopaminergic imaging as a biomarker for mild cognitive impairment with Lewy bodies | 2021 |
|
Gemma Roberts Dr James Lloyd Dr Joseph Kane Dr Rory Durcan Dr Sarah Lawley et al. | Cardiac 123I-MIBG normal uptake values are population-specific: Results from a cohort of controls over 60 years of age | 2021 |
|
Dr Calum Hamilton Professor Fiona Matthews Dr Paul Donaghy Professor John-Paul Taylor Professor John O'Brien et al. | Cognitive decline in mild cognitive impairment with Lewy bodies or Alzheimer’s disease: a prospective cohort study | 2021 |
|
Julia Schumacher Professor John-Paul Taylor Dr Calum Hamilton Dr Michael Firbank Dr Ruth Cromarty et al. | In vivo nucleus basalis of Meynert degeneration in mild cognitive impairment with Lewy bodies | 2021 |
|
Dr Michael Firbank Professor John O'Brien Dr Rory Durcan Dr Louise Allan Sally Barker et al. | Mild cognitive impairment with Lewy bodies: blood perfusion with arterial spin labelling | 2021 |
|
Dr Paul Donaghy Dr Michael Firbank Professor Alan Thomas Dr James Lloyd Dr George Petrides et al. | Amyloid imaging and longitudinal clinical progression in dementia with Lewy bodies | 2020 |
|
Dr Gemma Roberts Dr James Lloyd Dr George Petrides Professor John O'Brien Professor Alan Thomas et al. | Cardiac 123I-MIBG planar heart to mediastinum ratios depend on patient size; Phantom studies suggest SPECT-CT could improve quantification | 2020 |
|
Dr Paul Donaghy Dr Michael Firbank Dr George Petrides Dr James Lloyd Nicola Barnett et al. | Diffusion imaging in dementia with Lewy bodies: Associations with amyloid burden, atrophy, vascular factors and clinical features | 2020 |
|
Dr Paul Donaghy Dr Michael Firbank Dr Dipayan Mitra Dr George Petrides Dr James Lloyd et al. | Microbleeds in dementia with Lewy bodies | 2020 |
|
Julia Schumacher Professor John-Paul Taylor Dr Calum Hamilton Dr Michael Firbank Dr Ruth Cromarty et al. | Quantitative EEG as a biomarker in mild cognitive impairment with Lewy bodies | 2020 |
|
Dr Gemma Roberts Dr James Lloyd Dr George Petrides Dr Paul Donaghy Dr Joseph Kane et al. | 123I-FP-CIT striatal binding ratios do not decrease significantly with age in older adults | 2019 |
|
Dr Joseph Kane Dr Gemma Roberts Dr George Petrides Dr James Lloyd Professor John O'Brien et al. | 123I-MIBG scintigraphy utility and cut-off value in a clinically representative dementia cohort | 2019 |
|
Dr Gemma Roberts Dr Joseph Kane Dr James Lloyd Dr George Petrides Professor John O'Brien et al. | A comparison of visual and semi-quantitative analysis methods for planar cardiac 123I-MIBG scintigraphy in dementia with Lewy bodies | 2019 |
|
Dr Paul Donaghy Dr Michael Firbank Dr James Lloyd Dr George Petrides Professor Alan Thomas et al. | Beta-amyloid deposition maps onto hippocampal and subiculum atrophy in dementia with Lewy bodies | 2019 |
|
Professor Alan Thomas Dr Paul Donaghy Dr Gemma Roberts Dr Sean Colloby Nicola Barnett et al. | Diagnostic Accuracy of Dopaminergic Imaging in Prodromal Dementia with Lewy Bodies | 2019 |
|
Dr Gemma Roberts Dr James Lloyd Professor Alan Thomas
| Response to Dr. Kameyama’s letter to the editor | 2019 |
|
Gemma Roberts Dr James Lloyd Elizabeth Jefferson Dr Rory Durcan Dr Sarah Lawley et al. | Uniformity of cardiac 123I-MIBG uptake on SPECT images in older adults with normal cognition and patients with dementia | 2019 |
|
Dr James Lloyd Dr George Petrides Dr Paul Donaghy Dr Sean Colloby Professor Johannes Attems et al. | A new visual rating scale for Ioflupane imaging in Lewy body disease | 2018 |
|
Dr Paul Donaghy Dr Michael Firbank Professor Alan Thomas Dr James Lloyd Dr George Petrides et al. | Clinical and imaging correlates of amyloid deposition in dementia with Lewy bodies | 2018 |
|
Dr Paul Donaghy Professor John-Paul Taylor Professor John O'Brien Nicola Barnett Kirsty Olsen et al. | Neuropsychiatric symptoms and cognitive profile in mild cognitive impairment with Lewy bodies | 2018 |
|
Tony Fouweather Dr Deborah Stocken Dr James Lloyd Professor Peter Farr Professor Nick Reynolds et al. | An observer blinded randomised controlled pilot trial comparing localised immersion psoralen ultraviolet A (PUVA) with localised narrowband ultraviolet B (NBUVB) for the treatment of palmar hand eczema | 2017 |
|
Dr Michael Firbank Dr James Lloyd Professor David Williams Dr Robert Barber Dr Sean Colloby et al. | An evidence based algorithm for the utility of FDG-PET for diagnosing Alzheimer’s disease according to presence of medial temporal lobe atrophy | 2016 |
|
Claire Bamford Kirsty Olsen Dr Christopher Davison Nicola Barnett Dr James Lloyd et al. | Is there a preference for PET or SPECT brain imaging in diagnosing dementia? The views of people with dementia, carers, and healthy controls | 2016 |
|
Dr Michael Firbank Dr James Lloyd Professor John O'Brien
| The relationship between hallucinations and FDG-PET in dementia with Lewy bodies | 2016 |
|
Dr Michael Firbank Dr James Lloyd Professor John O'Brien
| CT-based attenuation and scatter correction compared with uniform attenuation correction in brain perfusion SPECT imaging for dementia | 2015 |
|
Dr Jennifer Latimer Dr James Lloyd Emeritus Professor Brian Diffey Professor Mark Birch-Machin
| Determination of the action spectrum of UVR-induced mitochondrial DNA damage in human skin cells | 2015 |
|
Professor John O'Brien Dr Michael Firbank Dr Christopher Davison Nicola Barnett Claire Bamford et al. | 18F-FDG PET and Perfusion SPECT in the Diagnosis of Alzheimer and Lewy Body Dementias | 2014 |
|
Dr Sean Colloby Professor John-Paul Taylor Dr Christopher Davison Dr James Lloyd Dr Michael Firbank et al. | Multivariate spatial covariance analysis of 99mTc-exametazime SPECT images in dementia with Lewy bodies and Alzheimer’s disease: utility in differential diagnosis | 2013 |
|
Dr Sophie Weatherhead Professor Peter Farr Dr David Jamieson Dr Jennifer Hallinan Dr James Lloyd et al. | Apoptosis of keratinocytes is a key mechanism in UVB-induced clearance of psoriasis | 2011 |
|
Dr Sophie Weatherhead Professor Peter Farr Dr David Jamieson Dr Jennifer Hallinan Dr James Lloyd et al. | Keratinocyte Apoptosis in Epidermal Remodeling and Clearance of Psoriasis Induced by UV Radiation | 2011 |
|
Dr Sophie Weatherhead Professor Peter Farr Dr James Lloyd Professor Nick Reynolds
| Keratinocyte apoptosis is an important mechanism in the remodelling of psoriatic plaques by ultraviolet B | 2011 |
|
Dr Jennifer Latimer Dr James Lloyd Professor Mark Birch-Machin
| The action spectrum of UVR-induced damage within an 11 kb segment of mitochondrial DNA in human skin cells | 2011 |
|
Dr Sean Colloby Dr Michael Firbank Dr Sanjeet Pakrasi Dr James Lloyd Dr Ian Driver et al. | A comparison of Tc-99m-exametazime and I-123-FP-CIT SPECT imaging in the differential diagnosis of Alzheimer's disease and dementia with Lewy bodies | 2008 |
|
Dr Ross Flockhart Emeritus Professor Brian Diffey Professor Peter Farr Dr James Lloyd Professor Nick Reynolds et al. | NFAT regulates induction of COX-2 and apoptosis of keratinocytes in response to ultravioloet radiation exposure | 2008 |
|
Dr James Lloyd Emeritus Professor Brian Diffey Professor John Matthews Professor Peter Farr
| A randomized comparison of selective broadband UVB and narrowband UVB in the treatment of psoriasis | 2007 |
|
Dr Shyamal Wahie Dr James Lloyd Professor Peter Farr
| Positive photocontact responses are not elicited to sunscreen ingredients exposed to UVA prior to application onto the skin | 2007 |
|
Dr Shyamal Wahie Dr James Lloyd Professor Peter Farr
| Sunscreen ingredients and labelling: A survey of products available in the UK | 2007 |
|
Professor Muzlifah Haniffa Dr James Lloyd Dr Clifford Lawrence
| The use of a spectrophotometric intracutaneous analysis device in the real-time diagnosis of melanoma in the setting of a melanoma screening clinic | 2007 |
|
Dr James Lloyd
| Untitled | 2007 |
|
Dr Philip Taylor Dr James Lloyd
| Evidence-based practice of photopheresis 1987-2001: A report of a workshop of the British Photodermatology Group and the U.K. Skin Lymphoma Group | 2006 |
|
Dr James Lloyd
| Practical points for nuclear cardiology | 2006 |
|
Dr Sean Colloby Professor David Williams Professor David Burn Dr James Lloyd Professor Ian McKeith et al. | Progression of dopaminergic degeneration in dementia with Lewy bodies and Parkinson's disease with and without dementia assessed using 123I-FP-CIT SPECT | 2005 |
|
Dr Peter Lamb Professor Michael Griffin Professor Alastair Burt Dr James Lloyd Dr Daya Karat et al. | Sentinel node biopsy to evaluate the metastatic dissemination of oesophageal adenocarcinoma | 2005 |
|
Dr James Lloyd
| The effect of imaging time, radiopharmaceutical, full fat milk and water on interfering extra-cardiac activity in myocardial perfusion single photon emission computed tomography | 2005 |
|
Professor Muzlifah Haniffa Dr James Lloyd Dr Clifford Lawrence
| The role of a skin-imaging device as a diagnostic aid in a melanoma screening clinic | 2005 |
|
Emeritus Professor Brian Diffey Professor Peter Farr Dr James Lloyd
| An update and guidance on narrowband ultraviolet B phototherapy: a British Photodermatology Group workshop report | 2004 |
|
Professor Peter Farr Emeritus Professor Brian Diffey Dr James Lloyd
| Implication for photosensitive patients of ultraviolet A exposure in vehicles | 2004 |
|
Dr Sharmila Das Dr James Lloyd Dr David Walshaw Professor Peter Farr
| Provocation testing in polymorphic light eruption using fluorescent ultraviolet (UV) A and UVB lamps | 2004 |
|
Dr Peter Lamb Dr James Lloyd Professor Alastair Burt Dr Daya Karat Nick Hayes et al. | The sentinel node concept in the metastatic dissemination of oesophageal adenocarcinoma | 2004 |
|
Dr James Lloyd
| Variation in calibration of hand-held ultraviolet (UV) meters for psoralen plus UVA and narrow-band UVB phototherapy | 2004 |
|
Dr Sharmila Das Dr James Lloyd Professor Peter Farr
| Measurement of the minimal phototoxic dose is important for optimal psoralen plus ultraviolet A treatment of psoriasis | 2003 |
|
Dr James Lloyd
| Uncertainty in calibration of ultraviolet radiometers | 2003 |
|
Dr James Lloyd
| Diagnostic patterns of regional atrophy on MRI and regional cerebral blood flow change on SPECT in young onset patients with Alzheimer's disease, frontotemporal dementia and vascular dementia | 2002 |
|
Dr James Lloyd
| Diagnostic value of high signal abnormalities on T2 weighted MRI in the differentiation of Alzheimer's, frontotemporal and vascular dementias | 2002 |
|
Emeritus Professor Brian Diffey Professor Peter Farr Julie Ferguson Dr James Lloyd
| Guidelines for dosimetry and calibration in ultraviolet radiation therapy: a report of a British Photodermatology Group workshop | 2002 |
|
Dr Sharmila Das Dr James Lloyd Dr David Walshaw Emeritus Professor Brian Diffey Professor Peter Farr et al. | Response of psoriasis to sunbed treatment: Comparison of conventional ultraviolet A lamps with new higher ultraviolet B-emitting lamps | 2002 |
|
Dr Sharmila Das Dr James Lloyd Professor Peter Farr
| Similar dose-response and persistence of erythema with broad-band and narrow-band ultraviolet B lamps | 2001 |
|